Displaying results 11 - 20 of 78 items found.

11. ALS Guidance on Drug Development FAQs FINAL-updated August 2017

(File; Sun Nov 05 10:21:00 CST 2017)

ALS Guidance on Drug Development Frequently Asked Questions What is an FDA Guidance? Food and Drug Administration ( FDA or the Agency) guidance documents explain the Agency???s current views on a regulatory topic and are typically d...

12. LOI-final-2015-call

(File; Wed Nov 25 09:36:00 CST 2015)

ALS ACT CLINICAL PHASE II STUDY Clinical Pilot Study Letter of Intent PLEASE TYPE IN THE BOXES AFTER THE QUESTION OR PROMPT. THE TEXT WILL APPEAR BOLD. DO NOT CHANGE THE FORMAT OF THIS FORM IN ANY WAY. Project Title: Principal Sc...

Description: Letter of Intent submission form

13. Svendsen Stem Cell Webinar June 2012

(File; Mon Jul 02 08:53:00 CDT 2012)

Stem Cells and Growth Factors: Separating Hype from HopeResearch Webinar June 19, 2012Host: ALS Association Chief Scientist Lucie Bruijn, Ph.D.Guest Speaker: Clive Svendsen, Ph.D.There is a lot of hype over stem cells but also a lot of h...

Description: June 2012 Research Webinar on Stem Cells

14. ATSDR

(File; Thu Feb 03 18:31:00 CST 2011)

Agency for Toxic Substances and Disease RegistryProtecting America’s Health from Toxic ExposureMedia inquiries: 404-639-3286atsdrmediainquiries@cdc.govATSDR launches national ALS registryFor Immediate Release: 10-20-10ATLANTA — In a grou...

15. 070714-Presymptom-Biomarkers-Benatar

(File; Mon Jul 07 15:55:00 CDT 2014)

Looking for ALS Before Diagnosis:The importance of Presymptomatic BiomarkersResearch Webinar: June, 30, 2014Host: ALS Association Chief Scientist Lucie Bruijn, Ph.D.Guest Speaker: Michael Benatar, M.D., Ph.D.By Richard RobinsonDetecting ...

Description: 070714-Presymptom-Biomarkers-Benatar

16. PDUFA_Comments 2012

(File; Sun May 06 15:51:00 CDT 2012)

National Office1275 K Street, N.W.Suite 1050Washington, DC 20005Telephone 202.407.8580Fax 202.289.6801Member National HealthCouncilOctober 24, 2011Division of Documents Management (HFA-305)c/o Janet Woodcock, MDDirector, Center for Drug ...

Description: PDUFA_Comments

17. Webinar Summary - Jeromin Biomarkers

(File; Mon Feb 11 07:24:00 CST 2013)

Progress in Developing Biomarkers for ALS Will Speed Clinical TrialsResearch Webinar December 13, 2012Host: ALS Association Chief Scientist Lucie Bruijn, Ph.D.Guest Speaker: Andreas Jeromin, Ph.D.Developing a biomarker for a neurological...

18. Jeromin Webinar December 2012

(File; Wed Feb 13 09:39:00 CST 2013)

Progress in Developing Biomarkers for ALS Will Speed Clinical TrialsResearch Webinar December 13, 2012Host: ALS Association Chief Scientist Lucie Bruijn, Ph.D.Guest Speaker: Andreas Jeromin, Ph.D.Developing a biomarker for a neurological...

Description: Jeromin Biomarkers for ALS December 2012 Research Webinar

19. FYI - Glutamate

(File; Fri Feb 15 12:32:00 CST 2013)

Glutamate Research Could Lead to ALS TreatmentDecades of research on the neurotransmitter glutamate have produced promising results thatcould lead to treatment for Amyotrophic Lateral Sclerosis (ALS). Scientists believe excessiveexposure...

Description: Glutamate Research Could Lead to ALS Treatment

20. RFA - Olney Award 2012

(File; Mon Apr 23 08:04:00 CDT 2012)

Richard Olney, MD, Clinician-Scientist DevelopmentThree-Year AwardCo-sponsored by the American Academy of Neurology Foundation and the ALS Association.Application Deadline: October 1, 2012The American Academy of Neurology (AAN) Foundatio...